Argitalpenak (40) Mª José Sánchez Sanz argitalpenak

2023

  1. Therapeutic potential of fetal liver cell transplantation in hemophilia A mice

    Haematologica, Vol. 108, Núm. 6, pp. 1544-1554

2022

  1. Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

    Leukemia and Lymphoma, Vol. 63, Núm. 14, pp. 3438-3447

  2. The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

    International journal of molecular sciences, Vol. 23, Núm. 15

2018

  1. Searching for a Cell-Based Therapeutic Tool for Haemophilia A within the Embryonic/Foetal Liver and the Aorta-Gonads-Mesonephros Region

    Thrombosis and Haemostasis, Vol. 118, Núm. 8, pp. 1370-1381

2017

  1. A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice

    Haematologica, Vol. 102, Núm. 4, pp. 647-655

  2. Characterization of a Fetal Liver Cell Population Endowed with Long-Term Multiorgan Endothelial Reconstitution Potential

    Stem Cells, Vol. 35, Núm. 2, pp. 507-521

2013

  1. Single site-specific integration targeting coupled with embryonic stem cell differentiation provides a high-throughput alternative to in vivo enhancer analyses

    Biology Open, Vol. 2, Núm. 11, pp. 1229-1238

2010

  1. Cis-regulatory remodeling of the SCL locus during vertebrate evolution

    Molecular and Cellular Biology, Vol. 30, Núm. 24, pp. 5741-5751

  2. Enhanced hematovascular contribution of SCL 3′ enhancer expressing fetal liver cells uncovers their potential to integrate in extramedullary adult niches

    Stem Cells, Vol. 28, Núm. 1, pp. 100-112

2009

  1. Cell fusion contributes to pericyte formation after stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 29, Núm. 3, pp. 480-485

  2. In vivo fate mapping with SCL regulatory elements identifies progenitors for primitive and definitive hematopoiesis in mice

    Mechanisms of Development, Vol. 126, Núm. 10, pp. 863-872

2008

  1. A novel mode of enhancer evolution: The Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity

    Genome Research, Vol. 18, Núm. 9, pp. 1422-1432

  2. Organ-injury-induced reactivation of hemangioblastic precursor cells

    Leukemia, Vol. 22, Núm. 1, pp. 103-113

2007

  1. The notch pathway positively regulates programmed cell death during erythroid differentiation

    Leukemia, Vol. 21, Núm. 7, pp. 1496-1503

2006

  1. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression

    Developmental Dynamics, Vol. 235, Núm. 11, pp. 3144-3155

2005

  1. Transgenic analysis of the stem cell leukemia +19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells

    Stem Cells, Vol. 23, Núm. 9, pp. 1378-1388

2004

  1. Kidney, blood, and endothelium: Developmental expression of stem cell leukemia during nephrogenesis

    Kidney International, Vol. 65, Núm. 4, pp. 1162-1169

  2. The scl +18/19 Stem Cell Enhancer Is Not Required for Hematopoiesis: Identification of a 5′ Bifunctional Hematopoietic-Endothelial Enhancer Bound by Fli-1 and Elf-1

    Molecular and Cellular Biology, Vol. 24, Núm. 5, pp. 1870-1883

2003

  1. Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection

    Journal of Biological Chemistry, Vol. 278, Núm. 44, pp. 43556-43563

2002

  1. Establishing the transcriptional programme for blood: The SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors

    EMBO Journal, Vol. 21, Núm. 12, pp. 3039-3050